|
|
||||||||
The Journal of Immunology, Vol 156, Issue 2 564-573, Copyright © 1996 by American Association of Immunologists
ARTICLES |
H Zhang, AR Shaw, A Mak and M Letarte
Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Canada.
Endoglin was first identified on a cell line derived from pre-B acute lymphoblastic leukemia. This 180-kDa homodimeric glycoprotein was then shown to be primarily expressed on endothelial cells and to bind the beta 1 and beta 3 isoforms of TGF-beta with high affinity. We now demonstrate that pre-B leukemic cells express a functional TGF-beta 1 receptor complex. The levels of mRNA for these receptors and for TGF- beta 1 were quantitated by PCR. HOON, G2, and NALM-6 cell lines express similar levels of mRNA for TGF-beta 1 and for TGF-beta receptor I (R-I) and receptor II (R-II). HOON cells express ten times more endoglin than G2 and NALM-6 cells, whereas all three cell lines have low levels of betaglycan relative to other cell types. The receptors were identified by affinity labeling with 125I-labeled TGF-beta 1, chemical cross- linking, and specific immunoprecipitation. Endoglin, R-II, and R-I were co-precipitated by Abs to either endoglin or R-II, indicating that these proteins are forming a receptor complex on leukemic cells; no betaglycan could be immunoprecipitated. The receptor complex is functional, as demonstrated by inhibition of proliferation of HOON cells (80%) and NALM-6 cells (60%) with 25 pM TGF-beta 1. Furthermore, the motility of HOON and NALM-6 cells on immobilized fibronectin, which appears to be alpha 4 beta 1-integrin mediated, was stimulated two- to threefold by TGF-beta 1. These results suggest that active TGF-beta 1 produced in the bone marrow microenvironment might stimulate the motility of normal pre-B cells and the peripheral dissemination of leukemic pre-B cells.
This article has been cited by other articles:
![]() |
T Gebhardt, A Lorentz, F Detmer, C Trautwein, H Bektas, M P Manns, and S C Bischoff Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor {beta}1 Gut, July 1, 2005; 54(7): 928 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Schmidt-Weber, M. Letarte, S. Kunzmann, B. Ruckert, C. Bernabeu, and K. Blaser TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin Int. Immunol., July 1, 2005; 17(7): 921 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lux, C. J. Gallione, and D. A. Marchuk Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms Hum. Mol. Genet., March 22, 2000; 9(5): 745 - 755. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |